PPARs in the brain

The 2007 WHO Classification of Tumours of the Central Nervous System

Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129

The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation

Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525

Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism

Desvergne, B., & Wahli, W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.5.0380 · Cited by 3,115

PPAR-γ agonists inhibit production of monocyte inflammatory cytokines

Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899

The many roles of chemokines and chemokine receptors in inflammation

Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523

World Cancer Report

Stewart, B. W., & Kleihues, P. (2003) · Cited by 2,389

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217

The WHO Classification of Tumors of the Nervous System

Kleihues, P., Louis, D. N., Scheithauer, B. W., RORKE, L. B., Reifenberger, G., Burger, P. C., & Cavenee, W. K. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.215 · Cited by 1,988

Endocannabinoid-Binding Receptors as Drug Targets

Gómez‐Cañas, M., Rodríguez‐Cueto, C., Satta, V., Hernández-Fisac, I., Navarro, E., & Fernández‐Ruíz, J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2728-0_6 · Cited by 17

Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease

Helisalmi, S., Tarvainen, T., Vepsäläinen, S., Koivisto, A. M., Hiltunen, M. O., & Soininen, H. S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.029 · Cited by 17

Pioglitazone Modulates Microglia M1/M2 Polarization Through PPAR-γ Pathway and Exerts Neuroprotective Effects in Experimental Subarachnoid Hemorrhage

Ding, Y., Wang, Y., Qi, M., Zhang, X., & Wu, D. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04664-w · Cited by 17

Camellia oil improves Aβ25-35-induced memory impairment by regulating the composition of the gut microbiota and lipid metabolism in mice

Guo, P., Zeng, M., Cao, B., Liu, M., Zhang, Y., Jia, J., Zhang, Q., Zhang, B., Wang, R., Xiong, W., et al. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105214 · Cited by 16

Uncovering ferroptosis in Parkinson’s disease via bioinformatics and machine learning, and reversed deducing potential therapeutic natural products

Wang, P., Chen, Q., Tang, Z., Wang, L., Gong, B., Li, M., Li, S., & Yang, M. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1231707 · Cited by 16

Oleoylethanolamide restores alcohol-induced inhibition of neuronal proliferation and microglial activity in striatum

Rivera, P., Silva‐Peña, D., Blanco, E., Vargas, A., Arrabal, S., Serrano, A., Pavón, F. J., Bîndilă, L., Lutz, B., de Fonseca, F. R., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.037 · Cited by 17

Roles of Cannabidiol in the Treatment and Prevention of Alzheimer’s Disease by Multi-target Actions

Zhang, X. B., Li, J., Gu, J.-H., & Zeng, Y.-Q. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210331162857 · Cited by 16

Validation of Brain Angiotensin System Blockade as a Novel Drug Target in Pharmacological Treatment of Neuropsychiatric Disorders

Wincewicz, D., & Braszko, J. J. (2017) · Pharmacopsychiatry · doi:10.1055/s-0043-112345 · Cited by 16

Cyanide-induced death of dopaminergic cells is mediated by uncoupling protein-2 up-regulation and reduced Bcl-2 expression

Zhang, X., Li, L., Zhang, L., Borowitz, J. L., & Isom, G. E. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.03.020 · Cited by 16

Transcription Factors as Therapeutic Targets in CNS Disorders

Kane, M., & Citron, B. A. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909789104820 · Cited by 15

Novel Thiazolidine-2,4-dione-trimethoxybenzene-thiazole Hybrids as Human Topoisomerases Inhibitors

Sinicropi, M. S., Ceramella, J., Vanelle, P., Iacopetta, D., Rosano, C., Khoumeri, O., Abdel‐Mohsen, S. A., AbdEl-Hady, W. H., & El‐Kashef, H. (2023) · Pharmaceuticals · doi:10.3390/ph16070946 · Cited by 15

Regulation of cyclooxygenase 2 expression by agonists of PPAR nuclear receptors in the model of endotoxin tolerance in astrocytes

Astakhova, A. A., Chistyakov, D. V., Pankevich, E. V., & Sergeeva, M. G. (2015) · Biochemistry (Moscow) · doi:10.1134/s0006297915100065 · Cited by 15

Cell proliferation and neuroblast differentiation in the dentate gyrus of high-fat diet-fed mice are increased after rosiglitazone treatment

Yoo, D. Y., Kim, W., Kim, D. W., Nam, S. M., Jung, H. Y., Kim, J. W., Lee, C. H., Choi, J. H., Won, M., Yoon, Y. S., et al. (2014) · Journal of Veterinary Science · doi:10.4142/jvs.2014.15.1.27 · Cited by 15

Loss of locus coeruleus noradrenergic neurons alters the inflammatory response to LPS in substantia nigra but does not affect nigral cell loss

Iravani, M. M., Sadeghian, M., Rose, S., & Jenner, P. G. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1223-1 · Cited by 15

Docosahexaenoic acid inhibits TNFα-induced ICAM-1 expression by activating PPARα and autophagy in human endothelial cells

Lin, H.-C., Lii, C., Lin, A., Li, C., Tsai, C.-H., Pan, S.-K., Yang, Y., Huang, C., Reshi, L., & Chen, H. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110811 · Cited by 15

Effect of isorhamnetin on carbonic anhydrase IX expression and tumorigenesis of bladder cancer by activating PPARγ/PTEN/AKT pathway

Zhang, P., Sun, Y., Shi, L., Sun, D., Wang, L., Feng, D., & Ding, C. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102048 · Cited by 14

Fenofibrate ameliorates nitroglycerin-induced migraine in rats: Role of CGRP/p-CREB/P2X3 and NGF/PKC/ASIC3 signaling pathways

Ruby, H. A., Sayed, R. H., Khattab, M. A., Sallam, N. A., & Kenway, S. A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176667 · Cited by 14

PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors

Benedetti, E., Galzio, R. J., D’Angelo, B., Cerù, M. P., & Cimini, A. (2010) · PPAR Research · doi:10.1155/2010/427401 · Cited by 14

Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery Occlusion and Reperfusion

Carta, G., Poddighe, L., Serra, M. P., Boi, M., Melis, T., Lisai, S., Murru, E., Muredda, L., Collu, M., Banni, S., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020426 · Cited by 16

Selective peroxisome proliferator‐activated receptor‐gamma modulator, INT131 exhibits anti‐inflammatory effects in an EcoHIV mouse model

Omeragic, A., Saikali, M. F., Currier, S., Volsky, D. J., Cummins, C. L., & Bendayan, R. (2019) · The FASEB Journal · doi:10.1096/fj.201901874r · Cited by 15

Up-regulated expression of peroxisome proliferator-activated receptor gamma in the hypothalamic-pituitary-adrenal axis of weaned pigs after Escherichia coli lipopolysaccharide challenge.

Liu, Y.-L., Shi, J., Lu, J., Che, Z.-Q., Zhu, H.-L., Hou, Y., Yin, Y.-L., Zhao, S.-J., Ding, B., & Liu, H.-M. (2010) · The Veterinary Journal · doi:10.1016/j.tvjl.2009.02.010 · Cited by 16

Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?

Cilibrasi, C., Butta, V., Riva, G., & Bentivegna, A. (2016) · PPAR Research · doi:10.1155/2016/7175067 · Cited by 13

PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in naïve, untreated cells and enhancement in LPS‐stimulated cells

Sergeeva, M. G., Aleshin, S. E., Grabeklis, S. A., & Reiser, G. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06931.x · Cited by 13

Understanding the molecular bridges between the drugs and immune cell

Dash, U. C., Nayak, V., Navani, H. S., Samal, R. R., Agrawal, P., Singh, A. K., Majhi, S., Mogare, D., Duttaroy, A. K., & Jena, A. B. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108805 · Cited by 13

Effects of PPARγ Ligands on Vascular Tone

Salomone, S., & Drago, F. (2012) · Current Molecular Pharmacology · doi:10.2174/1874-470211205020282 · Cited by 12

Environmental exposure to per- and polyfluoroalkyl substances and sleep disturbance in pregnant women: A prospective cohort study

Huang, Y., Nian, M., Yu, G., Tian, Y., Zhang, J., Jiang, F., & Zhang, J. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.156869 · Cited by 13

Impact of Cannabis-Based Medicine on Alzheimer’s Disease by Focusing on the Amyloid β-Modifications: A Systematic Study

Farkhondeh, T., Khan, H. Z., Aschner, M., Samini, F., Pourbagher‐Shahri, A. M., Aramjoo, H., Roshanravan, B., Hoyte, C. O., Mehrpour, O., & Samarghandian, S. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200708130745 · Cited by 12

Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma

Vallée, A., Vallée, J.-N., & Lecarpentier, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9050473 · Cited by 11

Brain metabolite clearance: impact on Alzheimer’s disease

Zolezzi, J. M., & Inestrosa, N. C. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9527-2 · Cited by 12

PPARβ/δ activation protects against corticosterone-induced ER stress in astrocytes by inhibiting the CpG hypermethylation of microRNA-181a

Ji, J., Zeng, X., Cao, L., Zhang, L., Zhao, Z., Yang, D., & Sun, X. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.022 · Cited by 11

Insulin inhibits Aβ fibrillogenesis through a decrease of the GM1 ganglioside‐rich microdomain in neuronal membranes

Yamamoto, N., Taniura, H., & Suzuki, K. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06620.x · Cited by 11

Transcriptomic Analysis Unveils Correlations between Regulative Apoptotic Caspases and Genes of Cholesterol Homeostasis in Human Brain

Picco, R., Tomasella, A., Fogolari, F., & Brancolini, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110610 · Cited by 11

Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations

Espinosa-Jiménez, T., Busquets, O., Cano, A. C., Sánchez‐López, E., Verdaguer, E., Parcerisas, A., Olloquequi, J., Auladell, C., Folch, J., Wahli, W., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.902047 · Cited by 10

Antiinflammatory effect of rosiglitazone via modulation of mRNA stability of interleukin 10 and cyclooxygenase 2 in astrocytes

Pankevich, E. V., Astakhova, A. A., Chistyakov, D. V., & Sergeeva, M. G. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917110050 · Cited by 9

Possible Involvement of PPAR-γ in the Anticonvulsant Effect of Aegle marmelos (L.) Correa

Bhatti, R., Singh, J., Nepali, K., & Ishar, M. P. S. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1064-6 · Cited by 9

Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets

Cardoso, S., Santos, R. X., Correia, S. C., Carvalho, C., Zhu, X., Lee, H., Casadesús, G., Smith, M. A., Perry, G. L., & Moreira, P. I. (2009) · Pharmaceuticals · doi:10.3390/ph2030250 · Cited by 10

Thiazolidinedione derivatives: emerging role in cancer therapy

Latambale, G., & Juvale, K. (2025) · Molecular Diversity · doi:10.1007/s11030-024-11093-3 · Cited by 9

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Levels in Adolescent with Bipolar Disorder and Their Relationship with Metabolic Parameters

Kaşak, M., Ceylan, M. F., Hesapçıoğlu, S. T., Şenat, A., & Erel, Ö. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02000-2 · Cited by 8

A reverse translational study of PPAR-α agonist efficacy in human and rodent models relevant to alcohol use disorder

Mason, B. J., Estey, D., Roberts, A. J., de Guglielmo, G., George, O., Light, J. M., Stoolmiller, M., Quello, S. B., Skinner, M., Shadan, F. F., et al. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2023.100604 · Cited by 9

(Arylthio)cyclopentenones derivatives prevent glutamate-induced HT22 cell death through a PPARγ-dependent pathway

Shibata, S., Furuta, K., Maeda, M., Suzuki, M., Oh‐hashi, K., Kiuchi, K., & Hirata, Y. (2009) · Brain Research · doi:10.1016/j.brainres.2009.08.015 · Cited by 8

Swimming reduces fatty acids-associated hypothalamic damage in mice

Nogueira, P. A. S., Pereira, M. P., Soares, J. J. G., Gomes, J. D. A. S., Ribeiro, D. L., Razolli, D. S., Velloso, L. A., Neto, M. B., & Zanon, R. G. (2019) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2019.101713 · Cited by 8

Microdeletions involving Chromosomes 12 and 22 Associated with Syndromic Duane Retraction Syndrome

Abu‐Amero, K. K., Kondkar, A. A., Oystreck, D. T., Khan, A. O., & Bosley, T. M. (2014) · Ophthalmic Genetics · doi:10.3109/13816810.2014.921317 · Cited by 8

Effects of prenatal PPAR-γ agonist rosiglitazone exposure on rat hippocampus development in a time-dependent manner: A stereological and histopathological study

Sağır, D., Eren, B., Yılmaz, B., Eren, Z., Keleş, O. N., & Gökçe, A. (2017) · Human & Experimental Toxicology · doi:10.1177/0960327117730883 · Cited by 8

Association study of rs1801282 PPARG gene polymorphism and immune cells and cytokine levels in a Spanish pregnant women cohort and their offspring

García-Ricobaraza, M., García-Bermúdez, M., Torres-Espínola, F. J., Moreno, M., Bléyéré, M. N., Díaz, L. E., Nova, E., Marcos, A., & Campoy, C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00694-3 · Cited by 8

Cannabinoids, the Blood–Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives

Ben‐Shabat, S., Yarmolinsky, L., Sharon, N., Zeadnaa-Aldda, T., Dayan, S., Khalfin, B., & Fleisher‐Berkovich, S. (2026) · Biomolecules · doi:10.3390/biom16020225 · Cited by 7

Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets

Dey, A. D., Mannan, A., Dhiman, S., & Singh, T. G. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06617-6 · Cited by 8

Type II nuclear receptors with potential role in Alzheimer disease

Muñoz-Cabrera, J., Adrián, S.-H., & Arboleda, G. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100940 · Cited by 9

Neuroprotective potential of saroglitazar in 6‐OHDA induced Parkinson's disease in rats

Bhatt, R., Vaishnav, D. J., Airao, V., Sharma, T., Rachamalla, M., Mani, S., Gupta, A. K., Upadhye, V. J., Jha, S. K., Jha, N. K., et al. (2023) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14306 · Cited by 7

Regulation of Oligodendrocyte Differentiation and Myelination by Nuclear Receptors: Role in Neurodegenerative Disorders

Sandoval-Hernández, A. G., Contreras-Zarate, M. J., Jaramillo, J., & Arboleda, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-40764-7_14 · Cited by 7

APOE4 drives transcriptional heterogeneity and maladaptive immunometabolic responses of astrocytesPreprint

Lee, S., Williams, H. C., Gorman, A. A., Devanney, N. A., Harrison, D. A., Walsh, A. E., Goulding, D. S., Tuck, T., Schwartz, J. L., Zajac, D. J., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.06.527204 · Cited by 7

PPARα suppresses low-intensity-noise-induced body weight gain in mice: the activated HPA axis plays an critical role

Yan, Z., Luo, J., Wang, Y., Yang, J., Su, M., Jiang, L., Yang, J., Dai, M., & Liu, A. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01550-2 · Cited by 6

Ethnopharmacological Profile, Phytochemistry and Therapeutic Potential of Aegle marmelos L. for the Treatment of Neurological Disorders

Sharma, A., Gugulothu, D. B., Virmani, T., Sharma, A., Kumar, G., Singh, K., Jain, D., Bhuia, M. S., Chowdhury, R., Ahammed, N. T., et al. (2025) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/2275526 · Cited by 5

Saroglitazar Enhances Memory Functions and Adult Neurogenesis via Up-Regulation of Wnt/β Catenin Signaling in the Rat Model of Dementia

Mishra, S. K., & Mishra, V. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00167 · Cited by 5

Saroglitazar, a PPAR α/γ agonist alleviates 3-Nitropropionic acid induced neurotoxicity in rats: Unveiling the underlying mechanisms

Jakkamsetti, M. S., Kolusu, A. S., Rongala, S., Arakareddy, B. P., Nori, L. P., & Samudrala, P. K. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.09.004 · Cited by 4

Astaxanthin alleviates the microcystin-LR-induced intestinal inflammatory toxicity in zebrafish

Wu, Y., Liu, C., Shao, C., & Huang, Q. (2025) · Aquatic Toxicology · doi:10.1016/j.aquatox.2025.107462 · Cited by 5

Influence of the dose of ketamine used on schizophrenia-like symptoms in mice: A correlation study with TH, GAD67, and PPAR-γ

Rodrigues, T., Bressan, G. N., Krum, B. N., Soares, F. A. A., & Fachinetto, R. (2023) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2023.173658 · Cited by 6

Design and Synthesis of New Quinoxaline-thiazolidine-2,4-dione-isoxazole Conjugates as EGFR Targeting Agents

Srimath, K., Dasari, G., Thirukovela, N. S., Ravula, S., & Bandari, S. (2024) · Russian Journal of General Chemistry · doi:10.1134/s107036322407017x · Cited by 5

Druggability profile of stilbene-derived PPAR agonists: determination of physicochemical properties and PAMPA study

Linciano, P., Filippis, B. D., Ammazzalorso, A., Amoia, P., Cilurzo, F., Fantacuzzi, M., Giampietro, L., Maccallini, C., Petit, C., & Amoroso, R. (2019) · MedChemComm · doi:10.1039/c9md00286c · Cited by 5

Serum 15-d-PGJ2 and PPARγ levels are reduced in manic episode of bipolar disorder while IL-4 levels are not affected

Erzın, G., Aydemır, M. Ç., Yüksel, R. N., YAYLACI, E. T., Çakır, B., Sezer, S., & Göka, E. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1471882 · Cited by 6

Potential Benefits of Glitazones for Cancer and Vascular Disease

Pérez-Ortiz, J., Llorens, S., Llopis, J., Tranque, P., & Nava, E. (2008) · Current Drug Therapy · doi:10.2174/157488508784221271 · Cited by 4

PPARs and Anticancer Therapies

Robbins, M. E. C., Linard, C., & Panigrahy, D. (2010) · PPAR Research · doi:10.1155/2010/536415 · Cited by 5

Regulator of Lipid Metabolism NHR-49 Mediates Pathogen Avoidance through Precise Control of Neuronal Activity

Kwon, S., Park, K., & Yoon, K.-H. (2024) · Cells · doi:10.3390/cells13110978 · Cited by 3

The Strategy of Targeting Peroxisome Proliferator-Activated Receptor (PPAR) in the Treatment of Neuropsychiatric Disorders

Matrisciano, F., & Pinna, G. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_22 · Cited by 5

High glucose inhibits neural differentiation by excessive autophagy via peroxisome proliferator-activated receptor gamma

Pan, Y., Qiu, D., Chen, S., Han, X., & Li, R.-M. (2023) · European Journal of Histochemistry · doi:10.4081/ejh.2023.3691 · Cited by 4

Cardarin Effect on the Formation of Histopathological and Behavioral Abnormalities in the Lithium-Pilocarpine Model of Temporal Lobe Epilepsy in Rats

Subkhankulov, M. R., Sinyak, D. S., Guk, V. A., Postnikova, T. Y., Roginskaya, A. I., & Zubareva, O. E. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s002209302401023x · Cited by 4

The Energy Crisis in Parkinson’s Disease: A Therapeutic Target

Abou-Hamdan, M., Cornille, E., Khrestchatisky, M., de, M. B. A. B., & Gharib, B. (2011) · InTech eBooks · doi:10.5772/17369 · Cited by 5

The relationship of lipid imbalance and chronic inflammation mediated by PPAR

Čavojský, T., Bilka, F., & Paulíková, I. (2016) · Česká a slovenská farmacie · doi:10.36290/csf.2016.001 · Cited by 4

Upregulation of tripeptidyl-peptidase 1 by 3-hydroxy-(2,2)-dimethyl butyrate, a brain endogenous ligand of PPARα: Implications for late-infantile Batten disease therapy

Chakrabarti, S., Chandra, S., Roy, A., Dasarathi, S., Kundu, M., & Pahan, K. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.025 · Cited by 4

Ketogenic Diet and PPARgamma

Simeone, T. A. (2016) · doi:10.1093/med/9780190497996.003.0020 · Cited by 4

Activation of PPARα Attenuates IFNγ and IL-1β-induced Cell Proliferation in Astrocytes: Involvement of IL-6 Independent Pathway

Lee, J.-K., Seo, E.-M., Lee, S., Park, S., Sim, Y., Jung, J., Kim, S., & Suh, H. (2010) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2010.14.3.185 · Cited by 4

Cannabidiolic Acid Rescues Deficits in Hippocampal Long-Term Potentiation in Models of Alzheimer’s Disease: An Electrophysiological and Proteomic Analysis

Gil, B., Sullivan, M., Scaife, C., Glennon, J. C., & Herron, C. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104944 · Cited by 3

Review on the role of hypothalamic astrocytes in the neuroendocrine control of metabolism

Farhadi, Z., Khaksari, M., Alivirdiloo, V., Mehrjerdi, F. Z., Alborzi, N., Baktash, K. B., & Rezvani, M. E. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01465-9 · Cited by 3

A positive association between high dietary medium-chain fatty acids intake and depression: Mediation of inflammation

Zeng, L., & Zhang, F. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.186 · Cited by 3

Peroxisome Proliferator-Activated Receptor-Review

Adedapo, A. D. A., Asunloye, O. O., & Adeoye, B. O. (2018) · International Journal of Biochemistry Research & Review · doi:10.9734/ijbcrr/2018/40221 · Cited by 3

Role of peroxisome proliferator-activated receptor alpha in neurodegenerative diseases and other neurological disorders: Clinical application prospects

Wu, Z., Zhao, Y., Hao, S., An, M., Song, C., & Li, J. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01371 · Cited by 4

Effects of prenatal cannabis exposure on offspring mental health: A focus on the role of the immune system

Vecchiarelli, H. A., Baglot, S. L., Black, T., Choi, E. Y., Cupo, L., Sandberg, C., Siron, L., Chakravarty, M. M., Hill, M. N., Howland, J. G., et al. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106488 · Cited by 3

APOE4 drives maladaptive heterogeneity and immunometabolic responses of astrocytes

Lee, S., Williams, H. C., Gorman, A. A., Devanney, N. A., Harrison, D. A., Walsh, A. E., Goulding, D. S., Tuck, T., Schwartz, J. L., Zajac, D. J., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03698-2 · Cited by 8

Potential Therapeutic Strategies for Neurodegenerative Diseases

Farooqui, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6652-0_9 · Cited by 2

Peroxisome Proliferator Activated Receptors and Cannabinoids

Muñóz, E., Pollastro, F., Taglialatela‐Scafati, O., & Appendino, G. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00080-6 · Cited by 2

Tissue Distribution and Versatile Functions of PPARs

Youssef, J., & Badr, M. Z. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-420-3_5 · Cited by 2

Differential peroxisome proliferator activated receptors activity in a rodent model of amyotrophic lateral sclerosis.

Yan, Q., Yin, X. L., Wang, S., Wang, J., Jiang, H., Wang, X., Ren, M., & Feng, H. (2015) · Europe PMC (PubMed Central) · Cited by 2

Effect of Anakinra on the Gene Expression of Receptors Activated by the Peroxisome Proliferator in the Rat Brain in the Lithium Pilocarpine Model of Epilepsy

Roginskaya, A. I., Dyomina, A. V., Kovalenko, A. A., Zakharova, M. V., Schwarz, A. P., Melik-Kasumov, T. B., & Zubareva, O. E. (2022) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093022020260 · Cited by 2

Do amyloid-lowering strategies work clinically?

van Marum, R. J. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285608101376 · Cited by 2

Cardarin effect on the formation of histopathological and behavioral abnormalities in the lithium-pilocarpine model of temporal lobe epilepsy in rats

Subkhankulov, M. R., Sinyak, D. S., Guk, V. A., Postnikova, T. Y., Roginskaya, A. I., & Zubareva, O. E. (2024) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813924010096 · Cited by 1

Ketamine impairs the performance of male mice in novel recognition object test and reduces the immunoreactivity of GAD67 in the hippocampus: Role of pioglitazone

Rodrigues, T., Bressan, G. N., Juliani, P. Z., da Silva, M. E. B., & Fachinetto, R. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173950 · Cited by 1

Exploring GPR120/FFAR4 pharmacology: Unveiling novel therapeutic avenues through molecular signaling pathways for Alzheimer's disease intervention

Gogu, P., Bharti, J., Yadav, J. P., Grishina, M., Verma, A., Kumar, V., Singh, A. K., Verma, A., Kumar, P., Khalilullah, H., et al. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101061 · Cited by 1

Potential PPARγ Partial Agonists from Ascidian-Associated Bacillus subtilis J08J-1-B’-4 Enhance Glucose Uptake without Adipogenesis

Kim, E. L., Park, S.-J., Jang, C., Lee, Y. J., Nam, Y., Hwang, H.-J., Jang, E. S., & Lee, S. R. (2025) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-025-00701-4 · Cited by 1

Biochemical Aspects of Neuroinflammation

Farooqui, A. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-04111-7_2 · Cited by 1

How Do Subcellular Organelles Participate in Preconditioning-Conferred Neuroprotection?

Li, P., Leak, R. K., Gan, Y., Hu, X., Stetler, R. A., & Chen, J. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9695-4_19 · Cited by 1

Pro-Oxidant and Inflammatory Mediators Produced In Transgenic Mice (App/ Ps1)

Aguirre Rueda, D., & Aldasoro, M. (2013) · Biochemistry & Physiology Open Access · doi:10.4172/2168-9652.1000121 · Cited by 1

Distinct Roles of Cyclooxygenase-1 and Cyclooxygenase-2 in Inflammatory and Excitotoxic Brain Injury

Aïd, S., Choi, S., Toscano, C. D., & Bosetti, F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-514-9_8 · Cited by 1

Cytokines in Neurodegenerative Disorders

Pahan, K. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_12 · Cited by 1

Dietary n-9, n-6 and n-3 fatty acids modulate the oxidative stress in brain and liver of mice. Effect of trans fatty acids supplementation

Lavandera, J. V., Reus, V., Saín, J., Bernal, C., & González, M. A. (2021) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-200508 · Cited by 1

Corrigendum to “PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors”

Benedetti, E., Galzio, R. J., D’Angelo, B., Cerù, M. P., & Cimini, A. (2019) · PPAR Research · doi:10.1155/2019/4309068 · Cited by 1

THE EFFECT OF PPARγ ACTIVATION BY PIOGLITAZONE ON THE LIPOPOLYSACCHARIDE-INDUCED PGE 2 AND NO PRODUCTION: POTENTIALUNDERLYING ALTERATION OF SIGNALING TRANSDUCTION

Xing, B. (2008) · UKnowledge (University of Kentucky)

Neuroinflammation in first episodes of psychosis

Alcázar, M. B. (2013) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)

Alterations of mitochondrial biogenesis and alterations of mitochondrial antioxidant defense in Friedreich's ataxia

Marmolino, D., & Pandolfo, M. (2011) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles)

Regulation and expression of genes associated with neurodegeneration with brain iron accumulation

Polster, B. J. (2010) · doi:10.6083/m48c9t7k

UNIVERSITÁ DEGLI STUDI DI MILANO FACOLTÁ DI MEDICINA E CHIRURGIA

Ricerca, D. D. (2010)

Neuroprotección conferida por agonistas PPARs E IGF-1 y su impacto en vías de supervivencia en dos modelos in vitro de la enfermedad de Krabbe

Galarza, M., & Ernesto, D. (2014)

Drug Insight: effects mediated by peroxisome proliferator-activated receptor-γ in CNS disorders

Heneka, M. T., Landreth, G. E., & Hüll, M. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0586 · Cited by 97

PPARs in Alzheimer′s Disease

Kummer, M. P., & Heneka, M. T. (2008) · PPAR Research · doi:10.1155/2008/403896 · Cited by 78

doi:10.1155/2008/403896 Review Article PPARs in Alzheimer’s Disease

Kummer, M. P., & Heneka, M. T. (2008)

Chapter 22. PPARγ in Alzheimer's Disease

Heneka, M. T., & Kummer, M. P. (2010) · RSC drug discovery/RSC drug discovery series · doi:10.1039/9781849731072-00153

Impact and Therapeutic Potential of PPARs in Alzheimers Disease

Heneka, M. T., Reyes-Irisarri, E., Hull, M. J., & Kummer, M. P. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376325 · Cited by 124